Kodiak Sciences Balance Sheet
NASDAQ: KODHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Kodiak Sciences financial position
At the end of fiscal 2025, Kodiak Sciences reported total assets of $351.5 million, up 4.8% from a year earlier against total liabilities of $194.2 million. Shareholders' equity stood at $157.4 million, or 44.8% of assets. The company held $209.9 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 4.72, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Kodiak Sciences balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 209.86M | 168.07M | 285.51M | 190.43M | 731.51M | 944.40M | 211.80M | 88.25M | 1.40M | 9.62M |
| Short-Term Investments | — | — | 0 | 288.50M | 0 | 24.58M | 124.68M | — | — | — |
| Total Current Assets | 214.82M | 171.94M | 289.31M | 486.00M | 734.81M | 972.00M | 339.23M | 90.45M | 1.59M | — |
| Property, Plant & Equipment | 85.26M | 102.22M | 120.48M | 56.38M | 41.33M | 5.14M | 996.00K | 1.10M | 1.51M | — |
| Long-Term Investments | — | — | — | — | — | — | 11.70M | — | — | — |
| Total Assets | 351.53M | 335.58M | 479.37M | 666.63M | 904.22M | 1.07B | 358.87M | 92.19M | 3.24M | — |
| Accounts Payable | 12.86M | 3.92M | 13.61M | 9.13M | 12.43M | 8.65M | 2.62M | 1.05M | 3.36M | — |
| Total Current Liabilities | 45.53M | 25.57M | 41.73M | 52.50M | 64.68M | 31.42M | 11.71M | 4.83M | 9.16M | — |
| Total Liabilities | 194.15M | 185.29M | 213.59M | 230.46M | 240.90M | 206.60M | 13.51M | 5.36M | 21.96M | — |
| Shareholders' Equity | 157.38M | 150.29M | 265.78M | 436.17M | 663.32M | 860.75M | 345.36M | 86.83M | -68.74M | -41.08M |
| Retained Earnings | -1.56B | -1.33B | -1.15B | -892.04M | -558.22M | -291.23M | -158.13M | -110.77M | -69.32M | — |
| Net Cash (Debt) | 209.86M | 168.07M | 285.51M | 478.93M | 731.51M | 968.97M | 336.48M | 88.25M | 1.40M | 9.62M |
| Shares Outstanding | 61.76M | 52.73M | 52.51M | 52.33M | 51.83M | 51.11M | 44.41M | 36.83M | 7.94M | — |
This table shows 10 annual periods of Kodiak Sciences's balance sheet, from FY 2025 back to FY 2016, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow KOD's reporting calendar. What is a balance sheet?